NCT05613803 (PUFFIN) is a Phase 3 clinical trial of Fish oil in Asthma, sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust.

Who is sponsoring NCT05613803?

NCT05613803 is sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust.

What drugs are being tested in NCT05613803?

Interventions in NCT05613803: Fish oil, Placebo.

Is NCT05613803 still recruiting?

NCT05613803 is currently status unknown. Last updated 4 December 2023.

Last reviewed 2023-12-04 · How we verify

NCT05613803: PUFFIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Poly-unsaturated Fats for Improving Nasal Polyps and Asthma

Status unknown Phase 3 Last updated 4 December 2023

What this trial tests

Phase 3 trial testing Fish oil in Asthma in 98 participants. Status unknown.

Timeline

9 October 2023

Primary endpoint
31 August 2024

31 August 2024

Quick facts

Lead sponsor	Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	98
Start date	9 October 2023
Primary completion	31 August 2024
Estimated completion	31 August 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Fish oil — full drug profile →
Placebo

Conditions studied

Asthma — all drugs for Asthma →

Sponsor

Norfolk and Norwich University Hospitals NHS Foundation Trust

Who can join

18 and older, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Asthma is a syndrome compromising many phenotypes including N-ERD (caused by increased 4-series leukotriene (LT) production). n-3 PUFA supplementation modulates 4-series LT and has anti-inflammatory effects. However, other than in a pilot study with dietary manipulation, the effects of N-ERD are unknown. The primary objective is to determine whether n-3 PUFA supplementation in people with N-ERD can improve asthma control using the asthma control questionnaire (ACQ-7). This is a placebo controlled randomised controlled parallel multicentre study with of 6g per day of PUFA for 6 months in people with N-ERD and poor asthma control

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fish oil

Trials testing the same drug.

NCT06424860 — Fish Oil, Metformin and Heart Health in PCOS · Phase 1 · recruiting
NCT05971147 — Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation · NA · completed
NCT05869526 — A Comparison of the Effects of Krill Oil and Fish Oil Supplementation on Muscle Function in Older Adults · NA · completed
NCT05677074 — Do Patients With Fish or Shellfish Allergy Tolerate the Consumption of Fish Oil Supplements? A Clinical Study · NA · completed
NCT04768595 — Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex) · NA · unknown

Other recruiting trials for Asthma

Currently open trials in the same condition.

NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting

Other Norfolk and Norwich University Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

NCT07027098 — Influence of Perfluorocarbon Liquid (LIQUID) During Pars Plana Vitrectomy on Retinal Vessel Displacement in Primary Macu · NA · recruiting
NCT07163962 — THE B-BABIES STUDY: An Observational Study of Group B Vitamins in Preterm Infants · not yet recruiting
NCT06856122 — Pharmacogenomics to Improve Supportive Care Symptoms. · enrolling by invitation
NCT06186505 — Heat Therapy for Peripheral Arterial Disease (HEATPAD) · NA · not yet recruiting
NCT06910800 — Indwelling Pleural Catheters: a Self-management Intervention · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05613803 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norfolk and Norwich University Hospitals NHS Foundation Trust
Last refreshed: 4 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05613803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing